RXSIGHT INC. 2024-2025 Proxy Voting Records

Description as filed by funds: To elect three Class I directors to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified: J. Andy Corley

RXSIGHT INC.’s own tally for this item (“Elect Director: J. Andy Corley”): 19,801,689 for, 5,918,311 against, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our common stock to serve as our Class I directors to hold office until our 2028 annual meeting of stockholders and until their successors have been duly elected and qualified:”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 8,735,767 for, 1,168,301 against, 5,996 abstained.

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

Description as filed by funds: To elect three Class I directors to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified: Ron Kurtz, M.D.

RXSIGHT INC.’s own tally for this item (“Elect Director: Ron Kurtz, M.D.”): 24,110,940 for, 1,608,846 against, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our common stock to serve as our Class I directors to hold office until our 2028 annual meeting of stockholders and until their successors have been duly elected and qualified:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 9,741,509 for, 162,559 against, 5,996 abstained.

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

Description as filed by funds: To elect three Class I directors to serve until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified: Juliet Tammenoms Bakker

RXSIGHT INC.’s own tally for this item (“Elect Director: Juliet Tammenoms Bakker”): 19,758,469 for, 5,961,387 against, per its Form 8-K filed June 4, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following nominees were re-elected by the holders of our common stock to serve as our Class I directors to hold office until our 2028 annual meeting of stockholders and until their successors have been duly elected and qualified:”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 47 asset managers below reported 8,088,995 for, 1,168,079 against.

Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.

Description as filed by funds: To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.

RXSIGHT INC.’s own tally for this item (“2. Advisory Vote on Executive Compensation”): 22,365,356 for, 3,322,193 against — passed, per its Form 8-K filed June 4, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement based on the following results of voting:”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 52 managers: 9,042,889 for, 874,059 against, 5,996 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 155 managers: 15,979,110 for, 2,488,373 against, 3,447 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2025.

RXSIGHT INC.’s own tally for this item (“3. Ratification of Appointment of Independent Registered Public Accounting Firm”): 31,946,931 for, 92,057 against — passed, per its Form 8-K filed June 4, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified based on the following results of voting:”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 9,903,827 for, 241 against, 5,996 abstained.

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.